1 year return (CAGR)
-
Ernexa Therapeutics Inc. Warrants Exchange (NASDAQ, USD)
ERNAW
0.12
-0.01 (-4.64%)
NASDAQ
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
0.00
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.14 |
| Daily high | 0.16 |
| Daily low | 0.11 |
| Daily Volume | 96K |
| All-time high | 0.18 |
| 1y analyst estimate | - |
| Beta | 1.89 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ERNAW | S&P500 | |
| Current price drop from All-time high | -33.30% | -0.70% |
| Highest price drop | -78.18% | -56.47% |
| Date of highest drop | 13 Mar 2026 | 9 Mar 2009 |
| Avg drop from high | -35.42% | -10.68% |
| Avg time to new high | 8 days | 12 days |
| Max time to new high | 33 days | 1805 days |
